Expert consensus on the management of chronic lymphocytic leukaemia in Asia.

Asia BTK inhibitors Bcl-2 inhibitors Chronic lymphocytic leukaemia Treatment

Journal

Clinical and experimental medicine
ISSN: 1591-9528
Titre abrégé: Clin Exp Med
Pays: Italy
ID NLM: 100973405

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 04 11 2022
accepted: 18 01 2023
medline: 2 10 2023
pubmed: 17 2 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

In recent years, considerable progress has been made in the standard treatment for chronic lymphocytic leukaemia (CLL) due to the availability of new potent drugs. However, the majority of data on CLL were derived from Western populations, with limited studies and guidelines on the management of CLL from an Asian population perspective. This consensus guideline aims to understand treatment challenges and suggest appropriate management approaches for CLL in the Asian population and other countries with a similar socio-economic profile. The following recommendations are based on a consensus by experts and an extensive literature review and contribute towards uniform patient care in Asia.

Identifiants

pubmed: 36795237
doi: 10.1007/s10238-023-01007-2
pii: 10.1007/s10238-023-01007-2
pmc: PMC10543526
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

2895-2907

Informations de copyright

© 2023. The Author(s).

Références

N Engl J Med. 2019 May 30;380(22):2095-2103
pubmed: 31141631
Lancet. 2010 Oct 2;376(9747):1164-74
pubmed: 20888994
Lancet. 2020 Apr 18;395(10232):1278-1291
pubmed: 32305093
N Engl J Med. 2018 Mar 22;378(12):1107-1120
pubmed: 29562156
N Engl J Med. 2015 Dec 17;373(25):2425-37
pubmed: 26639149
Int J Clin Pract. 2021 Aug;75(8):e14258
pubmed: 33884738
Biol Blood Marrow Transplant. 2016 Dec;22(12):2117-2125
pubmed: 27660167
Nat Rev Clin Oncol. 2018 Aug;15(8):510-527
pubmed: 29777163
N Engl J Med. 2019 Jun 06;380(23):2225-2236
pubmed: 31166681
Genes Chromosomes Cancer. 2016 Jan;55(1):16-24
pubmed: 26391112
Cold Spring Harb Perspect Med. 2021 Feb 1;11(2):
pubmed: 32229611
J Clin Oncol. 2010 Oct 10;28(29):4473-9
pubmed: 20697090
Cancers (Basel). 2021 May 19;13(10):
pubmed: 34069354
Leuk Lymphoma. 1996 Aug;22(5-6):439-47
pubmed: 8882957
Lancet Oncol. 2020 Sep;21(9):1188-1200
pubmed: 32888452
Curr Hematol Malig Rep. 2020 Jun;15(3):168-176
pubmed: 32542586
N Engl J Med. 2000 Dec 14;343(24):1750-7
pubmed: 11114313
Blood. 2016 Jan 14;127(2):208-15
pubmed: 26486789
Blood. 2016 Jan 21;127(3):303-9
pubmed: 26492934
Blood. 2016 Aug 11;128(6):816-26
pubmed: 27301861
Leukemia. 2020 Mar;34(3):787-798
pubmed: 31628428
Blood. 2018 Jun 21;131(25):2745-2760
pubmed: 29540348
Clin Lymphoma Myeloma Leuk. 2017 Jun;17(6):382-389
pubmed: 28559149
Blood. 2019 Mar 14;133(11):1205-1216
pubmed: 30602617
Ann Oncol. 2021 Jan;32(1):23-33
pubmed: 33091559
J Clin Oncol. 2019 Oct 20;37(30):2722-2729
pubmed: 31295041
Am J Hematol. 2016 Nov;91(11):1090-1095
pubmed: 27465919
Br J Haematol. 1986 Mar;62(3):567-75
pubmed: 3954968
Biomark Res. 2020 Sep 7;8:40
pubmed: 32939265
Hemasphere. 2020 Sep 23;4(5):e473
pubmed: 33062946
Hematol Oncol. 2022 Apr;40(2):129-159
pubmed: 34713475
Cancer. 2019 May 1;125(9):1432-1440
pubmed: 30807655
Cytometry B Clin Cytom. 2018 Jan;94(1):121-128
pubmed: 29024461
Nature. 2015 Oct 22;526(7574):525-30
pubmed: 26466571
J Clin Oncol. 2020 Sep 1;38(25):2849-2861
pubmed: 32459600
Leuk Lymphoma. 2019 Oct;60(10):2348-2355
pubmed: 30773964
Exp Oncol. 2018 Dec;40(4):261-267
pubmed: 30593759
Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1064-77
pubmed: 21493873
J Hematol Oncol. 2016 Sep 15;9(1):88
pubmed: 27633522
JCO Glob Oncol. 2020 Jun;6:866-872
pubmed: 32579486
Rev Bras Hematol Hemoter. 2016 Oct - Dec;38(4):346-357
pubmed: 27863764
Cancer. 2019 Jan 1;125(1):135-143
pubmed: 30343488
Leukemia. 2003 Jan;17(1):133-7
pubmed: 12529670
N Engl J Med. 2014 Mar 20;370(12):1101-10
pubmed: 24401022
Lancet Oncol. 2016 Jul;17(7):928-942
pubmed: 27216274
Am J Hematol. 2019 Dec;94(12):1353-1363
pubmed: 31512258
Curr Oncol. 2018 Oct;25(5):e461-e474
pubmed: 30464698
Trials. 2017 Aug 22;18(1):387
pubmed: 28830517
Blood. 1999 Sep 15;94(6):1848-54
pubmed: 10477713
Leuk Lymphoma. 2016 Oct;57(10):2342-50
pubmed: 26732125

Auteurs

Eric Tse (E)

Division of Haematology, Medical Oncology and Haematopoietic Stem Cell Transplant, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong, China. ewctse@hku.hk.

Yok Lam Kwong (YL)

2.Division of Haematology, Medical Oncology and Haematopoietic Stem Cell Transplant, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong, China.

Yeow Tee Goh (YT)

Department of Haematology, Singapore General Hospital, Singapore, Singapore.

Ping Chong Bee (PC)

Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Soo Chin Ng (SC)

Subang Jaya Medical Centre (SJMC), Selangor, Malaysia.

Daryl Tan (D)

Mount Elizabeth Novena Hospital, Singapore, Singapore.

Priscilla Caguioa (P)

Section of Haematology, St Luke's Medical Center, University of Santo Tomas Hospital, Manila, Philippines.

Huynh Nghia (H)

Blood Transfusion and Haematology Hospital (BTH), Ho Chi Minh, Vietnam.

Teresita Dumagay (T)

Division of Haematology, Department of Medicine, Philippine General Hospital, Manila, Philippines.

Lalita Norasetthada (L)

Division of Haematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Suporn Chuncharunee (S)

Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Vivek Radhakrishnan (V)

Clinical Haematology Oncology and HCT, Tata Medical Centre, Kolkata, India.

Bhausaheb Bagal (B)

Department of Medical Oncology, Tata Memorial Centre, Parel, India.

Tubagus Djumhana Atmakusuma (TD)

Haematology-Medical Oncology Division, Dr. Cipto Mangunkusumo National General Hospital/ Universitas Indonesia, Jakarta, Indonesia.

Nadia Ayu Mulansari (NA)

Haematology-Medical Oncology Division, Dr. Cipto Mangunkusumo National General Hospital/ Universitas Indonesia, Jakarta, Indonesia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH